HWHuanhuan Wang

Huanhuan Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Huanhuan Wang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Wang

    Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China

    1 shared publication
  • Jinlong Wei

    Department of Radiation Oncology, The First Hospital of Jilin University, Changchun 130021, China; Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, 130021, China; NHC Key Laboratory of Radiobiology, School of Public Health of Jilin University, Changchun, 130021, China

    1 shared publication
  • Lihua Dong

    Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China

    1 shared publication
  • Lingbin Meng

    Department of Internal Medicine, Florida Hospital, Orlando, FL 32803, USA

    1 shared publication
  • Xin Jiang

    Jilin Provincial Key Laboratory of Radiation Oncology & Therapy and Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China

    1 shared publication
  • Ying Xin

    Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University 1 , Changchun, China

    1 shared publication

Latest Publications

  • Open Access

    Role of human papillomavirus in laryngeal squamous cell carcinoma: A meta‐analysis of cohort study

    by Huanhuan Wang, Jinlong Wei, Bin Wang, Lingbin Meng, Ying Xin, Lihua Dong, Xin Jiang

    Objective: To evaluate the association of human papilloma virus (HPV) infection with prognosis, specifically overall survival (OS) and disease‐free survival (DFS), in laryngeal squamous cell carcinoma (LSCC) patients.Method: A systematic review and meta‐analysis were performed according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. LSCC was confirmed on the basis of histopathology, whereas HPV status was confirmed by polymerase chain reaction.Results: A total of 6539 articles were initially searched from 8 databases, of which 11 studies were eligible for our review. A total of 1442 LSCC cases were included in this analysis. Eight studies examined 3‐year OS for LSCC. The pooled hazard ratio (HR) from the 8 studies was 0.29 (95% CI: 0.25‐0.33). There was a statistically significant difference in 3‐year OS between the HPV‐negative and ‐positive groups, with the latter having a better survival. There was no statistically significant differences in 5‐ and 10‐year OS. Five studies examined 3‐ and 5‐year DFS for LSCC, whereas only 3 studies examined 10‐year DFS. There was no statistically significant difference in 3‐, 5‐, and 10‐year DFS between the HPV groups.Conclusion: This study evaluated the survival impact of HPV infection in LSCC patients. The OS of the HPV‐positive group was better than that of the HPV‐negative group in terms of short‐term survival. Compared with the HPV‐negative group, the HPV‐positive group had a better trend of DFS, suggesting that a larger sample size and further exploration of the pathology and local control of HPV‐positive tumors are needed.